Redeye Orphan Drugs
VirtualAbliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.
Loading view.
Investor event
Redeye Investor Forum Online
VirtualCEO Ellen Donnelly will present the company at 1:20 p.m. CEST.
Fireside chat
Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company's CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm (28 September) and Lund (29 September). After a long stretch of stringent travel restrictions and two-dimensional zoom presentations, we would like to invite Abliva shareholders […]
Kvinnokvällen (Women’s night) Malmö
VirtualAbliva will attend Aktiespararna's Kvinnokvällen Malmö, on 19 October 2021.. CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.
BioStock Life Science Summit
VirtualAbliva will attend the BioStock Life Science Summit 2021. CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.
Audiocast with teleconference
VirtualAbliva invites to a conference call and an online presentation on June 1, 2022, at 14:00 CEST. Abliva's CEO Ellen Donnelly, CMO Magnus Hansson and CFO Catharina Johansson will inform about the financing and implementation of KL1333 Phase 2/3 study and answer questions. The presentation will be held in English. After the presentation, there will […]